肺栓塞设备辅助治疗的风险和益处 肺栓塞设备辅助治疗的风险和益处
Sofia Kim1, Michael Kim1, Arber Kodra1
1Department of Cardiology, Northwell Health Lenox Hill Hospital, New York.
概括
肺栓塞 (PE) 治疗是有争议的,特别是对于亚大规模的病例. 新的机械血栓切除装置提供了替代方案,但了解它们的风险和益处对于有效的患者管理至关重要.
科学领域:
- 心脏病学 心脏病学
- 肺部医学 肺部医学
- 干预性放射学 干预性放射学
背景情况:
- 肺栓塞 (PE) 是疾病和死亡的重要原因.
- 对于PE的最佳治疗策略,特别是低质量PE,仍然不清楚.
- 传统的治疗方法包括抗凝血,血栓溶解和手术.
研究的目的:
- 审查目前肺栓塞治疗的现状.
- 突出机械和吸收血栓切除技术的新兴作用.
- 强调了解PE管理中的特定设备风险和好处的重要性.
主要方法:
- 关于肺栓塞治疗方式的现有文献的综述.
- 分析新的机械血栓切除器械的出现和应用.
- 讨论病理生理学和管理下质量PE.
主要成果:
- 对于PE的最佳治疗方法尚未确定.
- 机械血栓切除技术重新点燃了药理和机械干预之间的辩论.
- 低质量PE在病理生理学和治疗方面提供了进一步研究的领域.
结论:
- 对PE的治疗选择需要仔细考虑风险和益处.
- 了解各种血栓切除器械的细微差别对于复杂的PE病例至关重要.
- 需要进一步的研究来确定对子质PE的最佳治疗方法.
相关概念视频
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
197
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
197
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
153
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
153
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
91
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
91
01:26Flail Chest-II
165
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
165
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
167
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
167